Sermorelin is a GHRH(1-29) analog peptide intended for controlled laboratory work. It is studied in experimental systems involving pituitary GHRH-receptor and pulsatile growth-hormone models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.
Research areas include:
• GHRH-receptor activation
• Pulsatile growth-hormone release
• Pituitary reserve and endocrine feedback
• GH/IGF-1-axis biomarker studies
Research limitations and safety:
• Published evidence and human safety data may be limited; composition, identity, purity, and experimental controls should be independently verified.
• No dosing, administration, or therapeutic-use guidance is provided.
being sold for research only.





Reviews
There are no reviews yet.